Atlas Trials

Once-a-day Regimen With Everolimus, Low Dose Cyclosporine and Steroids in Comparison With Steroid Withdrawal or Twice a Day Regimen With Everolimus, Low Dose Cyclosporine and Steroids.

Clinical trial NCT01023815 · COMPLETED

Trial details

NCT number
NCT01023815
Sponsor
Novartis
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
de Novo Kidney Transplant RecipientsRenal Transplantation
Start date
2009-04-01
Primary completion
2012-07-01
Enrollment
330

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.